CYRX

SEC source: 0001104659-25-055047 · tm2516629-1_4seq1.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,061

SEC source: 0001104659-25-028324 · tm2510559-3_4seq1.xml · nonDerivative · entry 1

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,087

F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-25-028322 · tm2510559-2_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,349

F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-25-028320 · tm2510559-1_4seq1.xml · nonDerivative · entry 1

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 762,419

F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights

SEC source: 0001104659-25-025196 · tm259699-4_4seq1.xml · nonDerivative · entry 2

ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,911

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-25-025194 · tm259699-3_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,419

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-25-025193 · tm259699-2_4seq1.xml · nonDerivative · entry 2

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,436

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-25-025192 · tm259699-1_4seq1.xml · nonDerivative · entry 2

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 765,399

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-25-025196 · tm259699-4_4seq1.xml · derivative · entry 3

ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-03-14

F3 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.

SEC source: 0001104659-25-025196 · tm259699-4_4seq1.xml · nonDerivative · entry 1

ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,051

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

SEC source: 0001104659-25-025194 · tm259699-3_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-03-14

F3 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.

SEC source: 0001104659-25-025194 · tm259699-3_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,078

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

SEC source: 0001104659-25-025193 · tm259699-2_4seq1.xml · derivative · entry 3

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2032-03-14

F3 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.

SEC source: 0001104659-25-025193 · tm259699-2_4seq1.xml · nonDerivative · entry 1

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,528

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

SEC source: 0001104659-25-025192 · tm259699-1_4seq1.xml · derivative · entry 3

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2032-03-14

F3 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.

SEC source: 0001104659-25-025192 · tm259699-1_4seq1.xml · nonDerivative · entry 1

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 770,019

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

SEC source: 0001104659-25-022644 · tm258882-3_4seq1.xml · nonDerivative · entry 2

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,528

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-25-022642 · tm258882-1_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,078

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-25-022643 · tm258882-2_4seq1.xml · nonDerivative · entry 2

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 740,019

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-25-022644 · tm258882-3_4seq1.xml · derivative · entry 3

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

SEC source: 0001104659-25-022644 · tm258882-3_4seq1.xml · nonDerivative · entry 1

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

SEC source: 0001104659-25-022642 · tm258882-1_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

SEC source: 0001104659-25-022642 · tm258882-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,334

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

SEC source: 0001104659-25-022643 · tm258882-2_4seq1.xml · derivative · entry 3

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

SEC source: 0001104659-25-022643 · tm258882-2_4seq1.xml · nonDerivative · entry 1

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 744,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

SEC source: 0001104659-24-128537 · tm2431099-1_4seq1.xml · derivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 53,334 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options vested ratably beginning on the 18th of each month for forty-eight months beginning on 1/18/2015.

SEC source: 0001104659-24-128537 · tm2431099-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-125631 · tm2430199-1_4seq1.xml · derivative · entry 3

Mandalam Ramkumar · CIK 0001611439 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,834 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.

F3 · derivative.exercise_date: The options vested ratably over forty-eight months on the 18th day of each month beginning on 1/18/2015.

SEC source: 0001104659-24-125631 · tm2430199-1_4seq1.xml · nonDerivative · entry 2

Mandalam Ramkumar · CIK 0001611439 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,497

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.10 to $7.81, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-125631 · tm2430199-1_4seq1.xml · nonDerivative · entry 1

Mandalam Ramkumar · CIK 0001611439 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.

SEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · derivative · entry 6

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,862 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F4 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015.

SEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · nonDerivative · entry 4

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 735,942

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.34 to $6.60, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · nonDerivative · entry 3

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 758,759

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

SEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · derivative · entry 5

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,862

Underlying: Common Stock · 59,150 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F4 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015.

SEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · nonDerivative · entry 2

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 731,897

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.31 to $6.66, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · nonDerivative · entry 1

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 781,897

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

SEC source: 0001104659-24-124748 · tm2429945-1_4seq1.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,561

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.40 to $6.60, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · derivative · entry 9

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,012

Underlying: Common Stock · 60,000 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F5 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015.

SEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 6

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 722,747

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.47 to $6.93, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 5

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 772,747

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

SEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · derivative · entry 8

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,012

Underlying: Common Stock · 60,440 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F5 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015.

SEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 4

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 712,747

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.48 to $6.935, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 3

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 762,747

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

SEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · derivative · entry 7

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,452

Underlying: Common Stock · 60,215 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F5 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015.

SEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 2

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 702,307

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.94, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 1

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 752,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

SEC source: 0001104659-24-092969 · tm2422715-1_4seq1.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,061

SEC source: 0001104659-24-091339 · tm2422188-1_4seq1.xml · nonDerivative · entry 2

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,561

SEC source: 0001104659-24-091339 · tm2422188-1_4seq1.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,561

SEC source: 0001104659-24-086387 · tm2421024-1_4seq1.xml · derivative · entry 3

Mandalam Ramkumar · CIK 0001611439 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,167 shares

Expires 2024-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options vested ratably over twelve months on the 29th day of each month beginning on 9/29/14.